The BioFriend BioMask reduces the bio-burden of germs on the mask, effectively reducing the wearer’s exposure to germs and reducing the risk of healthcare-associated infections. Additionally, in independent laboratory tests, the BioFriend BioMask facemask inactivated 99.99 percent of tested pandemic and seasonal strains of influenza A and B viruses in five minutes.
Read the company news release about BioFriend BioMask.
Related Articles on Infection Control:
Survey: 64% of Americans Don’t Believe They’re Safer From Germs in a Hospital
Contrast Agent Could Help Detect Infections Through Imaging
Study: MRSA Bundle Implementation Needs the Right Multidisciplinary Team
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
